Skip to content
lsd.com

Indication

Amyotrophic Lateral Sclerosis

2 registered trials testing Psilocybin for this indication, 2 recruiting now.

Sponsors register this under 2 different names, all collected here: ALS (Amyotrophic Lateral Sclerosis) · Amyotrophic Lateral Sclerosis

2
Registered trials
2
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Amyotrophic Lateral Sclerosis trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Amyotrophic Lateral Sclerosis

TrialStatusPhaseSubstanceSites
Psilocybin Therapy for Psychological Distress in Palliative PatientsNCT06782724 · University Medical Center GroningenRecruitingPhase 2psilocybin4
Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisNCT06656702 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.